Fragmin

Fragmin (Dalteparin Sodium) is a low-molecular-weight heparin used for anticoagulation. It is commonly administered via subcutaneous or intravenous routes, including during haemodialysis. This medication helps prevent blood clots in various medical conditions.

Fragmin is primarily used for anticoagulation, helping to prevent blood clots in conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used during haemodialysis to maintain blood flow and prevent clotting in the dialysis circuit. Additionally, Fragmin may be used for other conditions where anticoagulation is necessary, as determined by a healthcare provider.

Common effects of Fragmin may include bruising, bleeding, and pain at the injection site. Some individuals may experience allergic reactions or changes in blood cell counts. It is important to monitor for signs of unusual bleeding or bruising and report any severe or persistent side effects to a healthcare provider.

Fragmin should be handled with care to avoid contamination. It is important to follow proper administration techniques, especially when using the subcutaneous route. Patients should be monitored for signs of bleeding or other adverse effects. Fragmin should be stored as per the manufacturer's instructions to maintain its efficacy.

Fragmin may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs), increasing the risk of bleeding. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol consumption should be moderated, as it may also increase the risk of bleeding.